title: [Gynecomastia secondary to rofecoxib].
authors.forename: Joaquín Antón
authors.initials: JA
authors.lastname: Martínez
authors.forename: Pilar
authors.initials: P
authors.lastname: Tejada González
authors.forename: Nora
authors.initials: N
authors.lastname: Gutiérrez Sanpedro
authors.forename: Pedro
authors.initials: P
authors.lastname: González Blanco
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D013450:Sulfones; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib
vernacular_title: Ginecomastia secundaria a rofecoxib.